መነሻ › Hemophilia B › New York
በNew York ለHemophilia B የሚደረጉ ክሊኒካዊ ጥናቶች
ለHemophilia B የሚደረጉ 5 ጥናቶች በNew York ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
Official study text (English)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- Cornell University||Joan & Sanford I. Weill Medical College, New York
- Weill Cornell Medical College-New York Presbyterian Hospital, New York
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ወንዶች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05568719ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Western New York BloodCare, Buffalo
- Northwell Health Hemostasis and Thrombosis Center at Long Island Jewish and Cohen Children's Medical Center, Hyde Park
- Weill Cornell Medical College - New York Presbyterian Hospital, New York
- እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT04398628Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- Northwell Health HTC, New Hyde Park
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ1 እስከ 74 · ወንዶች · የተሻሻለው በ1 ጁላይ 2026 · NCT05145127An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
- American Thrombosis and Hemostasis Network, Rochester
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ፌብሩ 2026 · NCT06008938SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
- Northwell Health, Long Island Jewish, New Hyde Park
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ12 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ12 ጃንዩ 2026 · NCT04647227ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።